Regenerative medicine is attracting increasing attention in fertility care, particularly among women with diminished ovarian reserve, low AMH, poor ovarian response or age-related decline in ovarian function. Three approaches frequently discussed are Platelet-Rich Plasma (PRP), exosome therapy and stem cell therapy. Although all three are associated with regenerative medicine, they are not the same treatment.